COVID-19: Vaccine Information for Providers

Recent News

Overview

Webinars

Upcoming

Date/Time: Friday, May 14, at 1 p.m.
Registration: Register through WebEx

Recent

More Information on Vaccines



See guidance below for providers about COVID-19, including how you can get vaccinated.

Find a Vaccination Site and Vaccine Eligibility

For patients with upcoming appointments for the Johnson & Johnson/Janssen vaccine at NYC Health + Hospitals or Health Department sites, visit the NYC Vaccine Command Center for more information.

All New Yorkers age 16 and older are eligible to receive a vaccine. People who work or study in New York are also eligible. Some sites may only vaccinate people who live or work in NYC. Other sites may require residence in a certain borough or ZIP code.

The Pfizer-BioNTech vaccine is authorized for ages 16 and older. The Moderna and Johnson & Johnson/Janssen vaccines are authorized for ages 18 and older.

Register to Provide Vaccinations

Become a Vaccine Provider

NYC providers who want to participate in the city's COVID-19 vaccine program will need to enroll with the Citywide Immunization Registry (CIR). They must use the CIR to electronically sign a provider agreement, place their order and report all doses administered.

Order Vaccine Doses

Once your Provider Agreement is approved by the NYC Health Department (and if you have appropriate vaccine storage), you will receive instructions on how to order vaccine doses through the CIR.

You will be notified when supply increases and doses have been allocated to you. Vaccine will be shipped directly to your facility from the manufacturer or the CDC’s distribution center.

Due to the limited supply of vaccine, the specific vaccine available will be determined by manufacturer supply, vaccination site and vaccine allocation.

Billing

You must offer the COVID-19 vaccine to all eligible people (as per State guidance), regardless of insurance status or ability to pay.

You may not bill for the cost of the vaccine, but you are permitted to bill the recipient’s health insurance plan for an administration fee. If a recipient does not have health insurance, or if their insurance does not cover the administration fee, you can request reimbursement for the administration of the COVID-19 vaccine through the Federal Provider Relief Fund.

Vaccine Administration and Storage

Note: Translations are available for many of the patient-targeting documents at their respective websites.

Fact Sheets for Vaccine Providers

Fact Sheets for Recipients

You are required to communicate information consistent with these fact sheets to patients (and provide a copy or direct the patient to the fact sheet at the manufacturer's website) before they receive the respective vaccines.

Other Patient Handouts

Pre-Vaccination Screening

Vaccine Storage and Handling

Administration Standing Orders

How to Administer

Post-Injection Observation

You should observe the following groups of people for 30 minutes after vaccinating:

  • History of an immediate allergic reaction of any severity to a vaccine or injectable therapy
  • People with a contraindication to a different type of COVID-19 vaccine
  • History of anaphylaxis due to any cause

Observe all other people for 15 minutes after injection.

If a person has a contraindication to one type of vaccine, consider consultation with an allergist-immunologist or contacting the Clinical Immunization Safety Assessment COVIDvax project before administering the other vaccine type. Consult the Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Authorized in the United States for additional guidance.

Reporting

You must report each vaccine administration to both of the systems listed below. Patient consent is not required.

For information on reporting an adverse event in VAERS, see the Adverse Events Reporting section.

Vaccine Communication and Encouragement

Your recommendation is one of the strongest predictors that a patient will get vaccinated. Consider using these resources to help build vaccine confidence among staff and patients.

Note: Translations are available for many of the patient-targeting documents at their respective websites.

Presentations and Materials for Health Care Staff

Online Resources for Patients

Direct your patients to the COVID-19: Vaccine Eligibility page so they can stay up to date on who is eligible for the vaccine. Begin talking with them now about the benefits and risks of the COVID-19 vaccine.

Underlying Conditions

Vaccine Benefits

Science

Handouts for Patients

Some of the below documents will soon be updated to include new eligibility groups.

Outreach

How the Vaccines Work

General FAQs and Resources

After Vaccination

These handouts include tips for before a patient leaves the vaccination site, and what to do if they feel side effects.

Pharmacies

For the most up-to-date New York State guidance for retail pharmacies, visit the State’s webpage on vaccine prioritization guidance.

  • Webinar Slides: COVID-19 Vaccine Updates for Independent Pharmacies (PDF, February 24). COVID-19 vaccination in the retail pharmacy setting, including information on enrollment, ordering vaccine, Moderna vaccine storage and handling, clinical considerations, reporting, and prioritization. Visit the CDC website for the latest updates on Clinical Considerations, including contraindications and precautions.
  • Standing Orders: Non-patient-specific standing orders are available for administration of the Moderna and Johnson&Johnson/Janssen COVID-19 vaccines at retail pharmacies. To get these standing orders:

Long-Term Care Facilities

Mental Hygiene Providers

Note: The below webinar and slide deck pre-date the authorization of the Johnson & Johnson/Janssen adenovirus vector vaccine.

Physical Space and Workflow

An effective COVID-19 vaccination program may require changes to your scheduling, waiting room and patient flow.

Waiting Room

  • Determine if there are other areas where patients can wait if waiting room capacity is limited.
  • Plan for accommodations in case of inclement weather, when waiting outdoors is not possible.

Monitoring for Side Effects

  • Review CDC guidance on preparing for anaphylaxis (CDC).
  • Determine where patients can be safely monitored while still maintaining social distance, such as an exam room or observation area.
  • If you monitor patients in the exam room, allow time in your schedule for observation and managing exam room use.

Temporary Locations

Clinical Considerations and Safety

Clinical Considerations

Post-Vaccination Symptoms

Safety Data

Adverse Events Reporting

Certain adverse events must be reported to the Vaccine Adverse Event Reporting System (VAERS).

Best Practices and Quality Improvement

Resources including best practices to maximize efficacy and efficiency of your program.

  • FQHC COVID-19 Vaccination Best Practices (PDF, February 9): Suggestions for planning, implementation and promotion.
  • Hospital COVID-19 Vaccination Best Practices (PDF, January 7): Best practices in planning and coordination, vaccine administration, vaccine distribution, prioritization and eligibility, clinic screening and safety, and patient/staff communication.
  • Model for Improvement Framework (Institute for Healthcare Improvement): Resources for process improvement work, such as setting goals, establishing measures, and testing changes (Plan-Do-Study-Act or PDSA cycles).

Vaccine Authorization Process

The below resources outline the process for COVID-19 vaccine development, from research to clinical trials to Emergency Use Authorization (EUA).

FDA Reviews

Advisory Committee on COVID-19 (ACIP)

Journal Articles

Data on Vaccine Distribution

We encourage you to collect and report COVID-19 vaccine recipients’ race and ethnicity data to help us monitor inequities and address barriers to vaccine access and distribution. For details, see the Reporting header in the Storage and Administration section.

The following resources show data on vaccine allocation, distribution and administration.

Trainings and Webinars

Overview

Training Modules on COVID-19 Vaccines

Webinars

Past webinar videos and slides are provided here for reference. They may not contain the most up-to-date information.

2021

2020

Additional Resources